Literature DB >> 10485970

Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans.

S J Gatley1, N D Volkow, A N Gifford, J S Fowler, S L Dewey, Y S Ding, J Logan.   

Abstract

OBJECTIVES: Recent studies using positron emission tomography (PET) have established the relationship between an intravenous dose of cocaine and the percentage occupancy of the dopamine transporter in humans, and have documented the requirement of more than 50% occupancy for perception of the "high". The present experiments were conducted to examine dose-occupancy and dose-effect relationships in mice for cocaine and also for methylphenidate, a dopamine uptake blocker used in pediatric psychiatry.
METHODS: Percentage occupancies of the dopamine transporter by cocaine and methylphenidate were estimated after intravenous injection in mice from the displacement of in vivo binding of [(3)H]cocaine from the striatum. Locomotor activity was measured in a photocell apparatus.
RESULTS: The relationship between drug doses (milligrams of hydrochloride salt per kilogram body weight) and percentage occupancy of the dopamine transporter was indistinguishable for cocaine and methylphenidate, and corresponded to about 50% occupancy at 0.25 mg/kg and about 80% at 1 mg/kg. This was similar to the relationship between drug dose and transporter occupancy, previously measured in human and baboons using [(11)C]cocaine or [(11)C]d-threo-methylphenidate and PET. Methylphenidate increased locomotor activity in the mice substantially more than cocaine at the same dose and the same degree of dopamine-transporter receptor occupancy.
CONCLUSIONS: The range of dopamine-transporter occupancy required for behavioral activation in the mice was thus similar to that previously reported for experience of a cocaine- or methylphenidate-induced "high" in human subjects. Our results are consistent with other studies in which both cocaine and methylphenidate were evaluated in animal behavioral assays and were found to have very similar psychopharmacological properties.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485970     DOI: 10.1007/s002130051093

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  48 in total

Review 1.  Neuroimaging in drug abuse.

Authors:  Kimberly P Lindsey; S John Gatley; Nora D Volkow
Journal:  Curr Psychiatry Rep       Date:  2003-10       Impact factor: 5.285

2.  Repetitive methylphenidate administration modulates the diurnal behavioral activity pattern of adult female SD rats.

Authors:  Min J Lee; Pamela B Yang; Victor T Wilcox; Keith D Burau; Alan C Swann; Nachum Dafny
Journal:  J Neural Transm (Vienna)       Date:  2010-11-06       Impact factor: 3.575

Review 3.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

4.  Acute and chronic methylphenidate alters prefrontal cortex neuronal activity recorded from freely behaving rats.

Authors:  R Layla Salek; Catherine M Claussen; Adriana Pérez; Nachum Dafny
Journal:  Eur J Pharmacol       Date:  2012-01-25       Impact factor: 4.432

5.  Glutaminergic signaling in the caudate nucleus is required for behavioral sensitization to methylphenidate.

Authors:  Nicholas King; Samuel Floren; Natasha Kharas; Ming Thomas; Nachum Dafny
Journal:  Pharmacol Biochem Behav       Date:  2019-06-19       Impact factor: 3.533

6.  Faster onset and dopamine transporter selectivity predict stimulant and reinforcing effects of cocaine analogs in squirrel monkeys.

Authors:  Heather L Kimmel; Joann A O'Connor; F Ivy Carroll; Leonard L Howell
Journal:  Pharmacol Biochem Behav       Date:  2006-12-20       Impact factor: 3.533

7.  Nucleus accumbens lesions modulate the effects of methylphenidate.

Authors:  Adam Podet; Min J Lee; Alan C Swann; Nachum Dafny
Journal:  Brain Res Bull       Date:  2010-05-12       Impact factor: 4.077

8.  Sex differences in the behavioral response to methylphenidate in three adolescent rat strains (WKY, SHR, SD).

Authors:  Mircea I Chelaru; Pamela B Yang; Nachum Dafny
Journal:  Behav Brain Res       Date:  2011-08-25       Impact factor: 3.332

9.  Methylphenidate does not increase ethanol consumption in a rat model for attention-deficit hyperactivity disorder-the spontaneously hypertensive rat.

Authors:  Heleen Suzanne Soeters; Fleur Margaret Howells; Vivienne Ann Russell
Journal:  Metab Brain Dis       Date:  2008-07-30       Impact factor: 3.584

10.  Dexmethylphenidate hydrochloride in the treatment of attention deficit hyperactivity disorder.

Authors:  Feng Liu; Haruka Minami; Raul R Silva
Journal:  Neuropsychiatr Dis Treat       Date:  2006-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.